Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Emanuela Mazziotti

Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

Related publications

Long-Term Prognostic and Predictive Factors in 107 Stage II/III Breast Cancer Patients Treated With Anthracycline-Based Neoadjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
1997English

P1.16-01 Prognostic Variables Associated With Improved Outcomes in Stage III NSCLC Patients Treated With Consolidation Pembrolizumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-113 Prognostic Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients With Operable Stage III-N2 Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-48 Predictive Factors in NSCLC Patients With Stage IIIB/IV Treated With First Line Platinum-Doublet Chemotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Pretreatment Systemic Inflammation Response Index in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator

Cancer Management and Research
Oncology
2020English

Neutrophil‐to‐lymphocyte Ratio as a Prognostic Factor in Advanced Stage Ovarian Carcinoma Treated With Neoadjuvant Chemotherapy

International Journal of Gynecology and Obstetrics
MedicineGynecologyObstetrics
2019English

Prognostic and Predictive Values of Metabolic Parameters of 18f-FDG PET/CT in Patients With Non-Small Cell Lung Cancer Treated With Chemotherapy

Molecular Imaging
Nuclear MedicineRadiologyMolecular MedicineCondensed Matter PhysicsImagingBiotechnologyBiomedical Engineering
2019English

Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy